In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes
Open Access
- 15 October 2015
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 65 (2), 503-509
- https://doi.org/10.2337/db15-0936
Abstract
Platelet activation is persistently enhanced, and its inhibition by low-dose aspirin is impaired in type 2 diabetes mellitus. We investigated in vivo thromboxane (TX) and prostacyclin (PGI2) biosynthesis and their determinants, as well as aspirin responsiveness, in young adult subjects with type 1 diabetes mellitus (T1DM) without overt cardiovascular disease and stable glycemic control. The biosynthesis of TXA2 was persistently increased in subjects with T1DM versus matched healthy subjects, with females showing higher urinary TX metabolite (TXM) excretion than male subjects with T1DM. Microalbuminuria and urinary 8-iso-PGF2α, an index of in vivo oxidative stress, independently predicted TXM excretion in T1DM. No homeostatic increase in PGI2 biosynthesis was detected. Platelet COX-1 suppression by low-dose aspirin and the kinetics of its recovery after drug withdrawal were similar in patients and control subjects and were unaffected by glucose variability. We conclude that patients with T1DM and stable glycemic control display enhanced platelet activation correlating with female sex and microvascular and oxidative damages. Moreover, aspirin responsiveness is unimpaired in T1DM, suggesting that the metabolic disturbance per se is unrelated to altered pharmacodynamics. The efficacy and safety of low-dose aspirin in T1DM warrant further clinical investigation.Keywords
Funding Information
- Innovative Medicines Initiative (115006, the SUMMIT consortium)
- Catholic University of Rome (Linea D3.2 2013-70201169)
- Italian Ministry for University and Research (Fondo per il Sostegno dei Giovani, Anno 2012)
This publication has 23 references indexed in Scilit:
- Estimated Life Expectancy in a Scottish Cohort With Type 1 Diabetes, 2008-2010JAMA, 2015
- Cardiovascular Disease Risk Factors in Youth With Diabetes MellitusJournal of the American College of Cardiology, 2014
- Type 1 Diabetes Mellitus and Cardiovascular DiseaseJournal of the American College of Cardiology, 2014
- Type 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes AssociationDiabetes Care, 2014
- ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASDEuropean Heart Journal, 2013
- Enhanced platelet activity and thrombosis in a murine model of type I diabetes are partially insulin-like growth factor 1-dependent and phosphoinositide 3-kinase-dependentJournal of Thrombosis and Haemostasis, 2013
- Exacerbation of Glycoprotein VI-Dependent Platelet Responses in a Rhesus Monkey Model of Type 1 DiabetesJournal of Diabetes Research, 2013
- The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low‐dose aspirin in patients with and without diabetesJournal of Thrombosis and Haemostasis, 2012
- Twice daily dosing of aspirin improves platelet inhibition in whole blood in patients with type 2 diabetes mellitus and micro- or macrovascular complicationsThrombosis and Haemostasis, 2011
- Platelet Activation and AtherothrombosisThe New England Journal of Medicine, 2007